FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.ebm
Resource TypeArtifactAssessment
IdArtifactAssessment-385882.json
FHIR VersionR6

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Title: Recommendation Rating: ADA Obesity Management Recommendation 8.16


Rating for Recommendation: Recommendation: ADA Obesity Management Recommendation 8.16


ConceptSummaryRating
Rating System (coded as: rating-system from https://fevir.net/resources/CodeSystem/179423)undefinedADA Level of Evidence
Direction of Recommendation (coded as: direction-of-recommendation from https://fevir.net/resources/CodeSystem/179423)undefinedFavors intervention (coded as: RJCS-2021 from https://fevir.net/resources/CodeSystem/27834)
Ratings (coded as: ratings from https://fevir.net/resources/CodeSystem/179423)undefinedA
Certainty of Evidence (coded as: certainty-of-evidence from https://fevir.net/resources/CodeSystem/179423)A substantial body of evidence has now been accumulated, including data from numerous randomized controlled (nonblinded) clinical trials, demonstrating that metabolic surgery achieves superior glycemic control and reduction of cardiovascular risk factors in patients with type 2 diabetes and obesity compared with various lifestyle/medical interventions.ADA Level of Evidence A


Source1

{
  "resourceType": "ArtifactAssessment",
  "id": "385882",
  "meta": {
    "versionId": "11",
    "lastUpdated": "2025-08-14T17:38:12.311Z",
    "profile": [
      "http://hl7.org/fhir/uv/ebm/StructureDefinition/recommendation-rating"
    ]
  },
  "language": "en",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/artifact-description",
      "valueMarkdown": "An example using the ArtifactAssessment Resource for representation of the rating assigned to a recommendation."
    },
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    }
  ],
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "385882",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    }
  ],
  "title": "Recommendation Rating: ADA Obesity Management Recommendation 8.16",
  "citeAs": "Recommendation Rating: ADA Obesity Management Recommendation 8.16 [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 385882. Revised 2025-08-14. Available at: https://fevir.net/resources/ArtifactAssessment/385882. Computable resource at: https://fevir.net/resources/ArtifactAssessment/385882#json.",
  "artifactReference": {
    "reference": "Composition/179466",
    "type": "Composition",
    "display": "Recommendation: ADA Obesity Management Recommendation 8.16"
  },
  "relatesTo": [
    {
      "type": "derived-from",
      "targetReference": {
        "reference": "ArtifactAssessment/179469",
        "type": "ArtifactAssessment",
        "display": "Justification for Recommendation: ADA Obesity Management Recommendation 8.16"
      }
    }
  ],
  "content": [
    {
      "type": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "rating-system",
            "display": "Rating System"
          }
        ]
      },
      "classifier": [
        {
          "text": "ADA Level of Evidence"
        }
      ],
      "freeToShare": true
    },
    {
      "type": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "strength-of-recommendation",
            "display": "Strength of Recommendation"
          }
        ]
      },
      "freeToShare": true
    },
    {
      "type": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "direction-of-recommendation",
            "display": "Direction of Recommendation"
          }
        ]
      },
      "classifier": [
        {
          "coding": [
            {
              "system": "https://fevir.net/resources/CodeSystem/27834",
              "code": "RJCS-2021",
              "display": "Favors intervention"
            }
          ]
        }
      ],
      "freeToShare": true
    },
    {
      "summary": "A substantial body of evidence has now been accumulated, including data from numerous randomized controlled (nonblinded) clinical trials, demonstrating that metabolic surgery achieves superior glycemic control and reduction of cardiovascular risk factors in patients with type 2 diabetes and obesity compared with various lifestyle/medical interventions.",
      "type": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "certainty-of-evidence",
            "display": "Certainty of Evidence"
          }
        ]
      },
      "classifier": [
        {
          "text": "ADA Level of Evidence A"
        }
      ],
      "freeToShare": true
    },
    {
      "type": {
        "coding": [
          {
            "system": "https://fevir.net/resources/CodeSystem/179423",
            "code": "ratings",
            "display": "Ratings"
          }
        ]
      },
      "classifier": [
        {
          "text": "A"
        }
      ],
      "freeToShare": true
    }
  ]
}